Trojko; Rudolf
Patent Applications and Registrations
Patent applications and USPTO patent grants for Trojko; Rudolf.The latest application filed is for "use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders".
- Trojko; Rudolf - Zagreb HR
- Trojko; Rudolf - Bjelovar HR
| Patent | Date |
|---|---|
| 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof Grant 7,262,309 - Mercep , et al. August 28, 2 | 2007-08-28 |
| Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders App 20070173499 - Mercep; Mladen ; et al. | 2007-07-26 |
| 1-or 3-thia-benznaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof App 20050137249 - Mercep, Mladen ; et al. | 2005-06-23 |
| 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof App 20050130964 - Mercep, Mladen ; et al. | 2005-06-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 